Chisato Itabashi,Kentaro Ohuchi,Yuna Roh et al.
Chisato Itabashi et al.
Local hyperthermia as a good treatment option for hands and feet warts in children: Case series report [0.03%]
儿童手足疣局部热疗治疗案例系列报告
Tingting Wang,Weifang Zhou,Xiaoyong Man et al.
Tingting Wang et al.
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysis [0.03%]
dupilumab在成人特应性皮炎初始治疗成功或发生不良事件后给药间隔的回顾性分析
Cataldo Patruno,Luca Potestio,Gabriella Fabbrocini et al.
Cataldo Patruno et al.
Strategies on long-term management of patients affected by atopic dermatitis (AD) undergoing treatment with dupilumab achieving good clinical response (GCR) or experiencing dupilumab-related adverse events (AEs) are scant. Data of patients ...
Intralesional combined furosemide and digoxin in cutaneous warts treatment: A randomized controlled clinical trial [0.03%]
富塞米和地高辛联合治疗皮肤寻常疣的病灶内注射疗法：随机对照临床试验
Amira Reda Lofty,Asmaa Mohamed Elbakry,Ghada Abdel Badea Omar et al.
Amira Reda Lofty et al.
Although being a benign lesion, Warts can affect the quality of life by causing discomfort, disfigurement, and social embarrassment besides the tendency to spread. Cutaneous wart treatment faces many challenges as the development of an anti...
Randomized Controlled Trial
Dermatologic therapy. 2022 Dec;35(12):e15935. DOI:10.1111/dth.15935 2022
Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis [0.03%]
托法替尼治疗难治性慢性自发性荨麻疹和血管性荨麻疹的疗效
Parvin Mansouri,Nikoo Mozafari,Reza Chalangari et al.
Parvin Mansouri et al.
The treatment of chronic urticaria (CU) is difficult, currently, antihistamines (AH) are the mainstay of treatment, however, up to 40% of patients do not respond to even high (four-fold) daily doses of AH. Tofacitinib is, a small-molecule t...
Case Reports
Dermatologic therapy. 2022 Dec;35(12):e15932. DOI:10.1111/dth.15932 2022
Surajit Gorai,Shahzaib Ahmad,Syeda Sadia Masood Raza et al.
Surajit Gorai et al.
Seborrheic keratosis (SK) is a common, benign tumor that can occur on everybody site and can be conservatively managed. Cosmetic concerns, especially when a lesion involves the facial area, are the most common reason for excision. SK shows ...
Sofia Nogueira,Maria Alexandra Rodrigues,Ron Vender et al.
Sofia Nogueira et al.
Although topical drugs are the mainstay of treatment for patients with mild-to-moderate psoriasis, the developments observed in this field in the last two decades have been limited. The most commonly used drugs are still vitamin D analogues...
Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients [0.03%]
司库奇尤单抗治疗384例西班牙患者的长期疗效和安全性：多中心研究
Pablo Chicharro,Mar Llamas-Velasco,Susana Armesto et al.
Pablo Chicharro et al.
The aim of the study was to assess the long-term effectiveness and safety of secukinumab in Spanish patients with moderate-to-severe psoriasis in a daily practice setting. Nationwide multicenter, observational, retrospective, non-interventi...
Multicenter Study
Dermatologic therapy. 2022 Dec;35(12):e15929. DOI:10.1111/dth.15929 2022
COVID-19 vaccine-related eruption of papules and plaques-A case report [0.03%]
与新冠疫苗有关的丘疹和斑块型皮损暴发一例报告
Aylin Kafelova,Valeria Mateeva,Jana Kazandjieva et al.
Aylin Kafelova et al.
Case Reports
Dermatologic therapy. 2022 Dec;35(12):e15927. DOI:10.1111/dth.15927 2022
Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta-analysis [0.03%]
奥马珠单抗治疗慢性自发性荨麻疹和诱导性荨麻疹疗效差异的系统评价和meta分析
Zhu-Han He,Shuo-Cheng Qiu,Zhi-Wei Huang et al.
Zhu-Han He et al.
This meta-analysis aimed to assess the efficacy of omalizumab in the treatment of refractory-to-antihistamines chronic induced urticaria (CIndU) in comparison with that of refractory-to-antihistamines chronic spontaneous urticaria (CSU). We...